Clinical Implication of Morphological Subtypes in Management of Intraductal Papillary Mucinous Neoplasm

被引:45
|
作者
Yamada, Suguru [1 ]
Fujii, Tsutomu [1 ]
Shimoyama, Yoshie [2 ]
Kanda, Mitsuro [1 ]
Nakayama, Goro [1 ]
Sugimoto, Hiroyuki [1 ]
Koike, Masahiko [1 ]
Nomoto, Shuji [1 ]
Fujiwara, Michitaka [1 ]
Nakao, Akimasa [3 ]
Kodera, Yasuhiro [1 ]
机构
[1] Nagoya Univ, Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 466, Japan
[2] Nagoya Univ Hosp, Dept Pathol, Nagoya, Aichi, Japan
[3] Nagoya Cent Hosp, Dept Surg, Nagoya, Aichi, Japan
关键词
INTERNATIONAL CONSENSUS GUIDELINES; PANCREATIC-JUICE CYTOLOGY; SURGICAL RESECTION; IPMN; CLASSIFICATION; TUMOR; RECURRENCE; PROGNOSIS; SURVIVAL;
D O I
10.1245/s10434-014-3565-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Morphological subtypes of intraductal papillary mucinous neoplasm (IPMN) have been established. Invasive IPMNs include colloid carcinoma and tubular carcinoma. Few studies have explored the association between the morphological and invasive subtypes in a large population. Clinical relevance of the morphological subtypes remains unclear. One hundred sixty-nine consecutive patients who underwent curative resection of IPMN were enrolled. The intraductal components were classified into four distinct epithelial subtypes: gastric, intestinal, pancreatobiliary, and oncocytic. The invasive components were classified as colloid or tubular. The numbers of patients with gastric, intestinal, pancreatobiliary, and oncocytic subtypes were 123, 42, 3, and 1, respectively. Fifty-six patients had invasive cancer (tubular type, 42; colloid type, 14). The proportions of gastric type IPMN within each histological grade were 88 % among adenomas, 43 % among noninvasive carcinomas, 41 % among minimally invasive carcinomas, and 74 % among invasive carcinomas. Gastric subtype was more commonly associated with branch duct type and intestinal subtype with main duct type, and these tendencies were statistically significant (P = 0.0131). Furthermore, there was a strong correlation between gastric and tubular types and between intestinal and colloid types (P < 0.0001). The 5-year survival rate among the 56 invasive cancers was 52.7 % for gastric type and 89.7 % for intestinal type, which was statistically significant (P = 0.030). Gastric type IPMN is mostly derived from branch duct IPMN and often demonstrates benign behavior, as seen with adenomas. However, once gastric type IPMN develops into invasive carcinoma, the survival rate is significantly lower than other types.
引用
收藏
页码:2444 / 2452
页数:9
相关论文
共 50 条
  • [41] Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current State of the Art and Ongoing Controversies
    Fong, Zhi Ven
    Ferrone, Cristina R.
    Lillemoe, Keith D.
    Fernandez-del Castillo, Carlos
    ANNALS OF SURGERY, 2016, 263 (05) : 908 - 917
  • [42] Predictors of Recurrence in Intraductal Papillary Mucinous Neoplasm: Experience with 183 Pancreatic Resections
    Megan Winner
    Irene Epelboym
    Helen Remotti
    James L. Lee
    Beth A. Schrope
    John A. Chabot
    John D. Allendorf
    Journal of Gastrointestinal Surgery, 2013, 17 : 1618 - 1626
  • [43] The role of pancreatic juice cytology in the diagnosis of pancreatic intraductal papillary mucinous neoplasm
    Tag-Adeen, Mohammed
    Ozawa, Eisuke
    Ogihara, Kumi
    Iwatsu, Shinichi
    Akazawa, Yuko
    Ohnita, Ken
    Adachi, Tomohiko
    Sumida, Yorihisa
    Nakao, Kazuhiko
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2018, 110 (12) : 775 - 781
  • [44] A case of intraductal papillary neoplasm of the bile duct accompanied by intraductal papillary mucinous neoplasm of the pancreas and hepatocellular carcinoma
    Kitahama, Takumi
    Yamane, Hisoka
    Mohri, Koichi
    Fukuoka, Eiji
    Yoshida, Toshihiko
    Yamagishi, Takashi
    Goto, Hironobu
    Furutani, Akinobu
    Otsubo, Dai
    Matsumoto, Taku
    Tanaka, Motofumi
    Fujino, Yasuhiro
    Tominaga, Masahiro
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (05) : 1536 - 1543
  • [45] Risk Factors Associated With the Postoperative Recurrence of Intraductal Papillary Mucinous Neoplasms of the Pancreas
    Park, Jongwook
    Lee, Kyu Taek
    Jang, Tae Hoon
    Seo, Yong Woo
    Lee, Kwang Hyuck
    Lee, Jong Kyun
    Jang, Kee-Taek
    Heo, Jin Seok
    Choi, Seong Ho
    Choi, Dong Wook
    Rhee, Jong Chul
    PANCREAS, 2011, 40 (01) : 46 - 51
  • [46] Outcomes of Primary Surveillance for Intraductal Papillary Mucinous Neoplasm
    Christy E. Cauley
    Joshua A. Waters
    Ryan P. Dumas
    Juliana E. Meyer
    Mohammad A. Al-Haddad
    John M. DeWitt
    Keith D. Lillemoe
    C. Max Schmidt
    Journal of Gastrointestinal Surgery, 2012, 16 : 258 - 266
  • [47] Outcomes of Primary Surveillance for Intraductal Papillary Mucinous Neoplasm
    Cauley, Christy E.
    Waters, Joshua A.
    Dumas, Ryan P.
    Meyer, Juliana E.
    Al-Haddad, Mohammad A.
    DeWitt, John M.
    Lillemoe, Keith D.
    Schmidt, C. Max
    JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (02) : 258 - 265
  • [48] Intraductal Papillary Mucinous Neoplasm of the Liver: GI Image
    Mo, Andrew
    Brat, Gabriel
    Spolverato, Gaya
    Pawlik, Timothy M.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2015, 19 (04) : 792 - 794
  • [49] Predictors of Malignant Intraductal Papillary Mucinous Neoplasm of the Pancreas
    Mimura, Takuya
    Masuda, Atsuhiro
    Matsumoto, Ippei
    Shiomi, Hideyuki
    Yoshida, Shiei
    Sugimoto, Maki
    Sanuki, Tsuyoshi
    Yoshida, Masaru
    Fujita, Tsuyoshi
    Kutsumi, Hiromu
    Ku, Yonsou
    Azuma, Takeshi
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (09) : E224 - E229
  • [50] Cystic lesion of pancreas - Intraductal papillary mucinous neoplasm
    Baijal, Rajiv
    Kumar, Praveen H. R.
    Gupta, Deepakkumar T.
    Shah, Nimish
    Amarapurkar, D.
    Gupte, Parijat
    JOURNAL OF DIGESTIVE ENDOSCOPY, 2013, 4 (03) : 93 - 96